A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)

Clinical trial NCT06191991 · COMPLETED

Trial details

NCT number: NCT06191991
Sponsor: Aligos Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2023-11-03
Primary completion: 2023-11-27
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.